Geode Capital Management’s Elevation Oncology ELEV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $198K | Sell |
|
|||||
|
2025
Q1 | $307K | Buy |
|
|||||
|
2024
Q4 | $651K | Buy |
|
|||||
|
2024
Q3 | $666K | Buy |
|
|||||
|
2024
Q2 | $2.79M | Buy |
|
|||||
|
2024
Q1 | $1.79M | Buy |
|
|||||
|
2023
Q4 | $124K | Hold |
|
|||||
|
2023
Q3 | $153K | Buy |
|
|||||
|
2023
Q2 | $207K | Buy |
|
|||||
|
2023
Q1 | $248K | Buy |
|
|||||
|
2022
Q4 | $85K | Sell |
|
|||||
|
2022
Q3 | $102K | Buy |
|
|||||
|
2022
Q2 | $36K | Hold |
|
|||||
|
2022
Q1 | $66K | Buy |
|
|||||
|
2021
Q4 | $126K | Buy |
|
|||||
|
2021
Q3 | $94K | Buy |
|